Moira Gilchrist

Dr. Gilchrist was appointed Chief Global Communications Officer in January 2026, having served as PMI’s Chief Communications Officer since January 2024. Prior to that, she was Vice President, Strategic and Scientific Communications, a role she assumed in 2018. Since joining PMI in 2006, Dr. Gilchrist held several positions, including leading the Reduced-Risk Products Corporate Affairs team, serving as Director of Scientific Engagement within the R&D function, and working in both product development and commercialization. Prior to joining the company, Dr. Gilchrist worked in the pharmaceutical sector for more than a decade. She was a principal consultant within PwC’s and IBM’s pharmaceutical industry consulting groups and held positions within both industry and nonprofit organizations as a developer of drug formulations. Dr. Gilchrist holds a degree in Pharmacy and a PhD in Pharmaceutical Sciences, both from the University of Strathclyde in Glasgow, Scotland.